Wang Huamao

Was appointed as a Director in September 2018 and the COO in February 2021. He was re-designated as an executive Director in February 2021.

Dr. Wang has also held positions at other members of the Group. He has been a director and the chief operating officer of CARsgen Therapeutics since October 2014, the general manager of CARsgen Pharmaceuticals since November 2017 and the general manager of CARsgen Diagnostics since November 2020.

Prior to joining the Group, Dr. Wang worked at Zhejiang Academy of Medical Sciences from July 2009 to January 2011, served as the deputy general manager of Shanghai Ruijin Biotechnology Co., Ltd. from January 2011 to June 2013, and the general manager of YIJIE Biotech (Shanghai) from July 2013 to October 2014.

Dr. Wang obtained his bachelor’s degree in biochemistry from Sichuan University, the PRC, in June 1999. He received his master’s degree and Doctor of Philosophy degree in pathogenic organisms from Fudan University, the PRC, in June 2003 and June 2009, respectively.